^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

TAK-007

i
Other names: TAK-007, TAK007, TAK 007, Anti-CD19 CAR NK-cell therapy, iC9/CAR.19/IL15-Transduced CB-NK Cells
Associations
Trials
Company:
Takeda, UT MD Anderson Cancer Center
Drug class:
CD19 inhibitor
Associations
Trials